Introduction, E.A. Tanagho and P.R. Carroll; how is it measured and defined?, S. Breslin; pain management for urological malignancies, W.R. McKay; impotence after radical pelvic surgery - physiology and management, T.F. Lue; nerve-sparing and continence preservation during radical prostatectomy, P. Narayan; the value of screening for prostatic carcinoma - a commentary, F. Hinman Jr; organ preservation in the management of pelvic rhabdomyosarcoma, C.A. Massad et al; use of the ileocecal segment for bladder substitution or continent urinary diversion, P.R. Carroll and J.W. McAninch; surveillance for clinical stage 1 nonseminomatous testis carcinoma - rationale and results of nerve-sparing retroperitoneal lymphadenectomy, R.S. Foster and J.P. Donohue et al; assessment of risk in metastatic testis carcinoma - impact on treatment, F. Bajorin et al; use of biological response modifiers for management of renal cell carcinoma, M. Wilkinson and F. Aronson.
